|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 271/06 | (2006.01) |
| A61K 31/4245 | (2006.01) |
| (11) | Number of the document | 2076501 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07838770.1 |
| Date of filing the European patent application | 2007-09-24 | |
| (97) | Date of publication of the European application | 2009-07-08 |
| (45) | Date of publication and mention of the grant of the patent | 2015-12-02 |
| (46) | Date of publication of the claims translation | 2016-05-10 |
| (86) | Number | PCT/US2007/020633 |
| Date | 2007-09-24 |
| (87) | Number | WO 2008/039431 |
| Date | 2008-04-03 |
| (30) | Number | Date | Country code |
| 847326 P | 2006-09-25 | US |
| (72) |
ALMSTEAD, Neil G., US
HWANG, Peter Seongwoo, US
MOON, Young-Choon, US
|
| (73) |
PTC Therapeutics, Inc.,
100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 3-[5-(2-fluorfenil)-[1,2,4]oksadiazol-3-il]benzenkarboksirūgšties kristalinės formos |
| CRYSTALLINE FORMS OF 3-[5-(2-FHJOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID |
| Payment date | Validity (years) | Amount | |
| 2024-08-20 | 18 | 347.00 EUR |
| 2025-09-24 |